[go: up one dir, main page]

WO2012169664A1 - Agent dermique externe et aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou extrait de celui-ci - Google Patents

Agent dermique externe et aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou extrait de celui-ci Download PDF

Info

Publication number
WO2012169664A1
WO2012169664A1 PCT/KR2011/004120 KR2011004120W WO2012169664A1 WO 2012169664 A1 WO2012169664 A1 WO 2012169664A1 KR 2011004120 W KR2011004120 W KR 2011004120W WO 2012169664 A1 WO2012169664 A1 WO 2012169664A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
extract
composition
functional food
rose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/004120
Other languages
English (en)
Korean (ko)
Inventor
모상현
서효현
강효석
이정훈
정대현
김수정
김형식
민지애
신동선
조문진
이유리
모지홍
이진형
곤도치에코
곤도요시다카
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GINZA TOMATO CO Ltd
BIO-FD&C Co Ltd
Original Assignee
GINZA TOMATO CO Ltd
BIO-FD&C Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GINZA TOMATO CO Ltd, BIO-FD&C Co Ltd filed Critical GINZA TOMATO CO Ltd
Priority to SG2012084125A priority Critical patent/SG186061A1/en
Publication of WO2012169664A1 publication Critical patent/WO2012169664A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Definitions

  • an object of the present invention is to activate the growth and proliferation of skin cells, has antioxidant and anti-wrinkle effect, and expresses various cytokines, which can promote immune disease improvement and metabolic activity. Or to provide an extract thereof.
  • the present invention relates to a rosette left tissue culture or extract thereof, and specifically, activates the growth and proliferation of skin cells, has antioxidant and antiwrinkle effect, and expresses various cytokines, thereby improving immune disease and metabolism.
  • the present invention relates to a rose pollens tissue culture or extract thereof, which can promote the activity and can be used for skin improvement, immune disease improvement, metabolic activity promotion, antioxidant use, and the like.
  • topical skin composition of the present invention may further comprise fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ions Any commonly used in type or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics It may contain adjuvants conventionally used in the cosmetic or dermatology field as other ingredients. In addition, the above components may be introduced in an amount generally used in the dermatology field.
  • Antioxidant Capacity of Rose's Peripheral Tissue Culture Extracts was determined using Antioxidant Assay Kit (Cayman, Cat No. 709001, Antioxidant Kit), using Trolox's Antioxidant Capacity as standard for various concentrations. It was measured by conversion to Trolox concentration.
  • gelatin contained an appropriate amount of glycerin, and was encapsulated with a film or a vegetable film composed of processed starch, glycerin, and thickened polysaccharides, and a total amount of 450 mg soft capsule was thermally formed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne un agent dermique externe et un aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou un extrait de celui-ci, et plus particulièrement un agent dermique externe et un aliment fonctionnel contenant un extrait de culture de tissu de placenta de rose comme principe actif. L'agent dermique externe et l'aliment fonctionnel contenant le produit cultivé à partir de tissu de placenta de rose ou l'extrait de celui-ci, selon la présente invention, activent les cellules cutanées par la croissance ou la prolifération des cellules cutanées, régénérant ainsi la peau et lissant les rides de manière efficace, et présentent un effet antioxydant supérieur par le fait qu'ils contiennent une substance d'activation physiologique.
PCT/KR2011/004120 2011-06-07 2011-06-07 Agent dermique externe et aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou extrait de celui-ci Ceased WO2012169664A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG2012084125A SG186061A1 (en) 2011-06-07 2011-06-07 Composition for skin external application and functional food containing rose placenta tissue culture or extract thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110054325A KR101372789B1 (ko) 2011-06-07 2011-06-07 장미 태좌 조직 배양물 또는 그 추출물을 함유하는 피부 외용제 조성물 및 기능성 식품
KR10-2011-0054325 2011-06-07

Publications (1)

Publication Number Publication Date
WO2012169664A1 true WO2012169664A1 (fr) 2012-12-13

Family

ID=47296209

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/004120 Ceased WO2012169664A1 (fr) 2011-06-07 2011-06-07 Agent dermique externe et aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou extrait de celui-ci

Country Status (4)

Country Link
KR (1) KR101372789B1 (fr)
MY (1) MY157534A (fr)
SG (1) SG186061A1 (fr)
WO (1) WO2012169664A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105232687A (zh) * 2015-11-30 2016-01-13 湖南省广林农业科技开发有限公司 玫瑰花及玫瑰果中有效成份的提取方法
KR102058444B1 (ko) * 2018-07-26 2019-12-23 주식회사 엑소코바이오 장미 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 화장료 조성물

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102157395B1 (ko) * 2013-10-28 2020-09-18 에스엠생명과학 주식회사 광천수 함유 배지에서 배양된 생열귀 캘러스 함유 화장료 조성물
KR102178963B1 (ko) * 2013-11-12 2020-11-13 주식회사 엘지생활건강 이소플라본 함량이 높은 두류 태좌 세포 배양 추출물의 제조 방법
KR101651321B1 (ko) * 2014-03-06 2016-08-25 주식회사 바이오에프디엔씨 알로에 베라 태좌 세포 배양 추출물을 함유한 피부 장벽 기능 강화용 항노화 피부 외용제 조성물
KR101726854B1 (ko) * 2014-11-14 2017-04-13 재단법인 홍천메디칼허브연구소 산양삼 추출물을 함유하는 피부 보습용 미스트 조성물
KR101766538B1 (ko) * 2015-11-09 2017-08-09 한국식품연구원 영실로부터 폴리페놀 성분을 포함하는 영실 추출물을 고수율로 수득하는 방법
KR101966374B1 (ko) 2017-11-28 2019-04-05 이노팜 주식회사 침향 추출물 및 베타글루칸(β-Glucan)을 포함하는 상처 치료 촉진용 조성물
KR102364823B1 (ko) * 2020-05-06 2022-02-21 연세대학교 산학협력단 피부 세포 재생용 화장료 조성물
EP4129317B1 (fr) * 2020-06-04 2025-12-31 Exocobio Inc. Composition pour l'anti-inflammation, la cicatrisation de plaies ou la stimulation de la cicatrisation des plaies, comprenant des exosomes dérivés de cellules souches de rose en tant que principe actif

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004075562A (ja) * 2002-08-12 2004-03-11 Yamakawa Boeki Kk 皮膚外用剤
JP2006273811A (ja) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd メイラード反応阻害剤
KR20110017566A (ko) * 2009-08-14 2011-02-22 (주)아모레퍼시픽 장미 추출물 함유 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004075562A (ja) * 2002-08-12 2004-03-11 Yamakawa Boeki Kk 皮膚外用剤
JP2006273811A (ja) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd メイラード反応阻害剤
KR20110017566A (ko) * 2009-08-14 2011-02-22 (주)아모레퍼시픽 장미 추출물 함유 조성물

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105232687A (zh) * 2015-11-30 2016-01-13 湖南省广林农业科技开发有限公司 玫瑰花及玫瑰果中有效成份的提取方法
KR102058444B1 (ko) * 2018-07-26 2019-12-23 주식회사 엑소코바이오 장미 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 화장료 조성물
US11690797B2 (en) 2018-07-26 2023-07-04 Exocobio Inc. Cosmetic composition comprising rose stem cell-derived exosome as effective ingredient

Also Published As

Publication number Publication date
KR20120135550A (ko) 2012-12-17
MY157534A (en) 2016-06-15
SG186061A1 (en) 2013-01-30
KR101372789B1 (ko) 2014-03-12

Similar Documents

Publication Publication Date Title
WO2012169664A1 (fr) Agent dermique externe et aliment fonctionnel contenant un produit cultivé à partir de tissu de placenta de rose ou extrait de celui-ci
JP5577443B2 (ja) バラ胎座組織培養物の抽出物およびその製造方法
KR101651833B1 (ko) 감귤류 과피 추출물을 포함하는 탈모 방지 또는 발모 촉진용 조성물
KR102152750B1 (ko) 장미 추출물을 포함하는 조성물
KR101846503B1 (ko) 금화규 및 포포 함유 탈모방지 또는 발모개선용 조성물
WO2018164369A1 (fr) Composition pour améliorer les rides de la peau, contenant un extrait d'hibiscus syriacus traité par une enzyme en tant que principe actif
KR102425559B1 (ko) 분갈 추출물 또는 이로부터 유래된 화합물을 포함하는 피부 개선용 조성물
KR101898250B1 (ko) 감탕나무 추출물을 포함한 피부 미백용 화장료 조성물
WO2016056781A1 (fr) Composition pour prévenir la chute des cheveux ou stimuler la pousse des cheveux comprenant un extrait d'artemisia umbelliformis
WO2018080039A1 (fr) Composition destinée à prévenir la chute des cheveux ou à améliorer la croissance des cheveux, contenant un extrait de feuilles de soja de couleur jaune
KR102209663B1 (ko) 조팝나무 추출물을 포함하는 피부질환 예방 또는 치료용 조성물
KR102078412B1 (ko) 황금찰수수 추출물 또는 그 분획물을 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물
KR102014903B1 (ko) 동백나무 겨우살이 추출물을 포함하는 최종당화산물 생성 억제 및 분해 촉진용 조성물
KR101895572B1 (ko) 울다비오시드 a 화합물을 함유하는 항산화 조성물
KR102154139B1 (ko) 고로쇠나무 수액의 발효액, 카카오닙스 추출물 및 석류피 추출물을 포함하는 조성물
KR101797567B1 (ko) 큰땅빈대 또는 애기땅빈대의 추출물 또는 분획물을 유효성분으로 포함하는 피부 주름 예방 또는 개선용 조성물
KR102374884B1 (ko) 황칠나무 추출물 및 산양삼 추출물을 유효성분으로 포함하는 화장료 조성물
KR102821283B1 (ko) 식물 추출물을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 화장료 조성물
KR102694743B1 (ko) 구기자 순의 생물전환 추출물을 유효성분으로 함유하는 항균용 조성물
KR101420913B1 (ko) 넓미역 추출물 함유 탈모방지 또는 발모개선용 조성물
KR20140030657A (ko) 병개암나무 추출물 또는 이의 분획물을 유효성분으로 함유하는 조성물 및 이의 이용
KR20200069616A (ko) 올벚나무를 포함하는 항염증용 조성물
WO2020138833A1 (fr) Composition comprenant un extrait de corylus heterophylla pour la prévention ou le traitement d'une maladie de la peau
KR20190143578A (ko) 효소처리된 홍삼 및 천마 추출물을 유효성분으로 함유하는 피부주름 예방 또는 개선용 조성물
KR102209664B1 (ko) 회잎나무 추출물을 포함하는 피부질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 9680/DELNP/2012

Country of ref document: IN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11867320

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 1201005957

Country of ref document: TH

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 15/04/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 11867320

Country of ref document: EP

Kind code of ref document: A1